I think all the long termers need to keep the faith and be conscious of that whilst its not a great SP at present agreed, we should acknowledge where we should be on the current status... We have never been in a more qualified situation to bring home the bacon IMO, & importantly a renewed hope for the individuals within the HT trial for a new chance at a quality life.
We need to survey where we are at now finally in HT, a low tox, qualified NHP, & with a plus 50-70% chance communicated by Management of commercialisation of our first drug, higher probabilities of partnership, & compare this to where we have been at much higher SP's +17's in a much, much lower qualifying & news stage. I thus feel the most confident that I ever have in 12+ years as a shareholder at success & beneficial outcomes for the supporters of PYC.
IMO, I am thinking 20 + mid year on news pos. flow & creeping to end of year news outcomes. I "suspect" a surprise announcement to please all for much higher; this purely based on the data, current stage, & interview comments of partnership probabilities based on data & HT stages to please us all on the ASX. The language & excitement seen in interviews on the 4 drugs does form some of my current opinion, however the data and senior management & stakeholders % loading also adds. The additional benefits of the AI partnership for additional revenue streams is a +. I remember the days of SP 1c & running on the smell of an oily rag with a 1m grant each year to keep the wheels turning to where we see ourselves today ! WOW, look at us now. I believe we are in for a bumper crop this year & I hope I'm not proved wrong all ! GLTAH. I'm still buying !
PYC Price at posting:
9.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)